

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cell adhesion mediated by integrin (GO:0033627) | 5.51577644 |
| 2 | plasma membrane repair (GO:0001778) | 4.65626095 |
| 3 | COPI coating of Golgi vesicle (GO:0048205) | 4.65306273 |
| 4 | Golgi transport vesicle coating (GO:0048200) | 4.65306273 |
| 5 | cardiac myofibril assembly (GO:0055003) | 4.54166619 |
| 6 | skin morphogenesis (GO:0043589) | 4.46779015 |
| 7 | * positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 4.31168610 |
| 8 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.30120752 |
| 9 | * regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 4.26648074 |
| 10 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 4.21334191 |
| 11 | * regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 4.11245818 |
| 12 | protein retention in ER lumen (GO:0006621) | 4.08886868 |
| 13 | hemidesmosome assembly (GO:0031581) | 4.04378023 |
| 14 | * regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.95178443 |
| 15 | myofibril assembly (GO:0030239) | 3.93483164 |
| 16 | cell communication by electrical coupling (GO:0010644) | 3.86932568 |
| 17 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 3.78794786 |
| 18 | sarcomere organization (GO:0045214) | 3.76877429 |
| 19 | endothelial cell morphogenesis (GO:0001886) | 3.76161647 |
| 20 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.64486220 |
| 21 | cellular response to vitamin (GO:0071295) | 3.61167930 |
| 22 | regulation of skeletal muscle contraction (GO:0014819) | 3.60845236 |
| 23 | daunorubicin metabolic process (GO:0044597) | 3.60620137 |
| 24 | polyketide metabolic process (GO:0030638) | 3.60620137 |
| 25 | doxorubicin metabolic process (GO:0044598) | 3.60620137 |
| 26 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.59678405 |
| 27 | relaxation of cardiac muscle (GO:0055119) | 3.53197729 |
| 28 | protein localization to endosome (GO:0036010) | 3.48967587 |
| 29 | muscle cell migration (GO:0014812) | 3.48876977 |
| 30 | endodermal cell differentiation (GO:0035987) | 3.43679004 |
| 31 | low-density lipoprotein particle clearance (GO:0034383) | 3.43360850 |
| 32 | mesenchymal-epithelial cell signaling (GO:0060638) | 3.43067259 |
| 33 | cardiac muscle contraction (GO:0060048) | 3.42743750 |
| 34 | * regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.40030328 |
| 35 | cell communication involved in cardiac conduction (GO:0086065) | 3.37837983 |
| 36 | positive regulation of osteoblast proliferation (GO:0033690) | 3.36822324 |
| 37 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.34455938 |
| 38 | cellular response to vitamin D (GO:0071305) | 3.33267854 |
| 39 | actin-myosin filament sliding (GO:0033275) | 3.32057011 |
| 40 | muscle filament sliding (GO:0030049) | 3.32057011 |
| 41 | mesodermal cell differentiation (GO:0048333) | 3.30955234 |
| 42 | cell-substrate junction assembly (GO:0007044) | 3.27394405 |
| 43 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.27258121 |
| 44 | COPII vesicle coating (GO:0048208) | 3.26317593 |
| 45 | regulation of transforming growth factor beta2 production (GO:0032909) | 3.24867408 |
| 46 | desmosome organization (GO:0002934) | 3.19433263 |
| 47 | peptidyl-proline hydroxylation (GO:0019511) | 3.18666554 |
| 48 | regulation of membrane repolarization (GO:0060306) | 3.17265214 |
| 49 | substrate-dependent cell migration (GO:0006929) | 3.16097992 |
| 50 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.13712328 |
| 51 | sodium ion export (GO:0071436) | 3.11695694 |
| 52 | membrane raft organization (GO:0031579) | 3.08751183 |
| 53 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 3.08306492 |
| 54 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.06469749 |
| 55 | regulation of sarcomere organization (GO:0060297) | 3.05958440 |
| 56 | hypotonic response (GO:0006971) | 3.05349061 |
| 57 | lung vasculature development (GO:0060426) | 3.04588659 |
| 58 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 3.04189493 |
| 59 | carnitine shuttle (GO:0006853) | 3.03764135 |
| 60 | cellular potassium ion homeostasis (GO:0030007) | 3.02668737 |
| 61 | protein heterotrimerization (GO:0070208) | 3.02382209 |
| 62 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.98622461 |
| 63 | regulation of actin filament-based movement (GO:1903115) | 2.98339371 |
| 64 | * regulation of cell communication by electrical coupling (GO:0010649) | 2.97655713 |
| 65 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 2.96676733 |
| 66 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.96647266 |
| 67 | cardiac muscle hypertrophy (GO:0003300) | 2.95692328 |
| 68 | chondrocyte proliferation (GO:0035988) | 2.95680334 |
| 69 | basement membrane organization (GO:0071711) | 2.92009760 |
| 70 | actomyosin structure organization (GO:0031032) | 2.91609919 |
| 71 | vesicle coating (GO:0006901) | 2.91115337 |
| 72 | regulation of relaxation of muscle (GO:1901077) | 2.89039806 |
| 73 | barbed-end actin filament capping (GO:0051016) | 2.86933301 |
| 74 | striated muscle hypertrophy (GO:0014897) | 2.86506944 |
| 75 | actin-mediated cell contraction (GO:0070252) | 2.84751127 |
| 76 | tricarboxylic acid cycle (GO:0006099) | 2.84506324 |
| 77 | positive regulation of extracellular matrix organization (GO:1903055) | 2.84163387 |
| 78 | * positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.83304217 |
| 79 | fatty acid transmembrane transport (GO:1902001) | 2.83001811 |
| 80 | protein localization to cell surface (GO:0034394) | 2.79552234 |
| 81 | cardiac muscle cell development (GO:0055013) | 2.79513395 |
| 82 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.78116391 |
| 83 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.77801661 |
| 84 | negative regulation of anoikis (GO:2000811) | 2.77723582 |
| 85 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.76637265 |
| 86 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.75733064 |
| 87 | potassium ion import (GO:0010107) | 2.72839959 |
| 88 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.72484634 |
| 89 | establishment of nucleus localization (GO:0040023) | 2.72215055 |
| 90 | epithelial cell-cell adhesion (GO:0090136) | 2.70798288 |
| 91 | striated muscle contraction (GO:0006941) | 2.70187374 |
| 92 | positive regulation of fatty acid oxidation (GO:0046321) | 2.69638335 |
| 93 | cardiac conduction (GO:0061337) | 2.68697851 |
| 94 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.68081964 |
| 95 | type B pancreatic cell proliferation (GO:0044342) | 2.67822831 |
| 96 | * protein hydroxylation (GO:0018126) | 2.66819097 |
| 97 | kidney mesenchyme development (GO:0072074) | 2.66697459 |
| 98 | substrate adhesion-dependent cell spreading (GO:0034446) | 2.66683497 |
| 99 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.66681077 |
| 100 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.65749467 |
| 101 | iron ion import (GO:0097286) | 2.64414216 |
| 102 | positive regulation of muscle hypertrophy (GO:0014742) | 2.63592618 |
| 103 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 2.63592618 |
| 104 | negative regulation of fatty acid transport (GO:2000192) | 2.63502141 |
| 105 | relaxation of muscle (GO:0090075) | 2.62988205 |
| 106 | cardiac cell development (GO:0055006) | 2.62748483 |
| 107 | regulation of sequestering of triglyceride (GO:0010889) | 2.62089186 |
| 108 | activation of protein kinase A activity (GO:0034199) | 2.62074792 |
| 109 | axon extension involved in axon guidance (GO:0048846) | 2.60926129 |
| 110 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.60926129 |
| 111 | * regulation of calcium ion transmembrane transport (GO:1903169) | 2.60361746 |
| 112 | * regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.60361746 |
| 113 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 2.59962613 |
| 114 | * regulation of striated muscle contraction (GO:0006942) | 2.58851516 |
| 115 | regulation of cofactor metabolic process (GO:0051193) | 2.58366214 |
| 116 | regulation of coenzyme metabolic process (GO:0051196) | 2.58366214 |
| 117 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.57635331 |
| 118 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.57521752 |
| 119 | regulation of epidermal growth factor-activated receptor activity (GO:0007176) | 2.57448193 |
| 120 | cell-substrate adherens junction assembly (GO:0007045) | 2.55160343 |
| 121 | focal adhesion assembly (GO:0048041) | 2.55160343 |
| 122 | actin filament depolymerization (GO:0030042) | 2.55052338 |
| 123 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.54062823 |
| 124 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 2.52853824 |
| 125 | adherens junction assembly (GO:0034333) | 2.51882215 |
| 126 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.51866374 |
| 127 | regulation of osteoblast proliferation (GO:0033688) | 2.51303345 |
| 128 | paraxial mesoderm development (GO:0048339) | 2.51127406 |
| 129 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.51025099 |
| 130 | regulation of the force of heart contraction (GO:0002026) | 2.50922281 |
| 131 | stress fiber assembly (GO:0043149) | 2.50625698 |
| 132 | actin filament-based movement (GO:0030048) | 2.49696779 |
| 133 | membrane repolarization during action potential (GO:0086011) | 2.49471012 |
| 134 | protein maturation by protein folding (GO:0022417) | 2.49343442 |
| 135 | cell migration involved in sprouting angiogenesis (GO:0002042) | 2.49281783 |
| 136 | muscle hypertrophy (GO:0014896) | 2.47859067 |
| 137 | positive regulation of glycogen biosynthetic process (GO:0045725) | 2.47478636 |
| 138 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.46196911 |
| 139 | membrane protein ectodomain proteolysis (GO:0006509) | 2.45898259 |
| 140 | regulation of extracellular matrix disassembly (GO:0010715) | 2.45307391 |
| 141 | nucleus localization (GO:0051647) | 2.45244335 |
| 142 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.45167860 |
| 143 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.45121417 |
| 144 | cardiac muscle cell action potential (GO:0086001) | 2.44921826 |
| 145 | negative regulation of chondrocyte differentiation (GO:0032331) | 2.43820575 |
| 146 | regulation of metalloenzyme activity (GO:0048552) | 2.43732454 |
| 147 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.42571281 |
| 148 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 2.42361725 |
| 149 | cardiac muscle adaptation (GO:0014887) | 2.42084086 |
| 150 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 2.42084086 |
| 151 | muscle hypertrophy in response to stress (GO:0003299) | 2.42084086 |
| 152 | apoptotic cell clearance (GO:0043277) | 2.41812620 |
| 153 | regulation of fatty acid oxidation (GO:0046320) | 2.40280207 |
| 154 | regulation of heart rate by cardiac conduction (GO:0086091) | 2.39649211 |
| 155 | cellular sodium ion homeostasis (GO:0006883) | 2.38307044 |
| 156 | collagen metabolic process (GO:0032963) | 2.38302697 |
| 157 | adult heart development (GO:0007512) | 2.38131166 |
| 158 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.37534618 |
| 159 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.37394144 |
| 160 | positive regulation of establishment of protein localization to plasma membrane (GO:0090004) | 2.35296032 |
| 161 | response to pheromone (GO:0019236) | 2.34205344 |
| 162 | glycogen catabolic process (GO:0005980) | 2.34142864 |
| 163 | extracellular matrix assembly (GO:0085029) | 2.33344025 |
| 164 | growth hormone secretion (GO:0030252) | 2.32993757 |
| 165 | glomerular basement membrane development (GO:0032836) | 2.31309120 |
| 166 | glomerular visceral epithelial cell development (GO:0072015) | 2.31198557 |
| 167 | retinal metabolic process (GO:0042574) | 2.31092018 |
| 168 | collagen fibril organization (GO:0030199) | 2.30734499 |
| 169 | regulation of anoikis (GO:2000209) | 2.30463298 |
| 170 | * regulation of cardiac muscle contraction (GO:0055117) | 2.30200949 |
| 171 | fatty acid homeostasis (GO:0055089) | 2.30039086 |
| 172 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.29864234 |
| 173 | multicellular organismal macromolecule metabolic process (GO:0044259) | 2.29378883 |
| 174 | membrane repolarization (GO:0086009) | 2.29161737 |
| 175 | negative regulation of protein activation cascade (GO:2000258) | 2.28913835 |
| 176 | protein targeting to Golgi (GO:0000042) | 2.28795147 |
| 177 | locomotory exploration behavior (GO:0035641) | 2.28735210 |
| 178 | negative regulation of complement activation (GO:0045916) | 2.27387844 |
| 179 | regulation of potassium ion transmembrane transport (GO:1901379) | 2.27190789 |
| 180 | regulation of potassium ion transmembrane transporter activity (GO:1901016) | 2.27042758 |
| 181 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.26927213 |
| 182 | carnitine transmembrane transport (GO:1902603) | 2.26685253 |
| 183 | cell-matrix adhesion (GO:0007160) | 2.26594733 |
| 184 | triglyceride catabolic process (GO:0019433) | 2.26323766 |
| 185 | heart morphogenesis (GO:0003007) | 2.26222985 |
| 186 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.26191294 |
| 187 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.26052952 |
| 188 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.25387849 |
| 189 | regulation of protein localization to plasma membrane (GO:1903076) | 2.25282851 |
| 190 | keratan sulfate catabolic process (GO:0042340) | 2.25247300 |
| 191 | heart trabecula formation (GO:0060347) | 2.25179341 |
| 192 | hippo signaling (GO:0035329) | 2.24930374 |
| 193 | regulation of heart rate (GO:0002027) | 2.24549893 |
| 194 | positive regulation of protein localization to plasma membrane (GO:1903078) | 2.23639287 |
| 195 | wound healing, spreading of epidermal cells (GO:0035313) | 2.22638265 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.12522986 |
| 2 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.70517470 |
| 3 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 3.41233848 |
| 4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.67580569 |
| 5 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.67513021 |
| 6 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.55046867 |
| 7 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 2.51397333 |
| 8 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 2.51397333 |
| 9 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.45168706 |
| 10 | * AR_21909140_ChIP-Seq_LNCAP_Human | 2.39208146 |
| 11 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.37340005 |
| 12 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.25047497 |
| 13 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.18757277 |
| 14 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 2.17625288 |
| 15 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 2.17169355 |
| 16 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.16926505 |
| 17 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 2.14833246 |
| 18 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 2.11336920 |
| 19 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.06651064 |
| 20 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.06651064 |
| 21 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 2.05817380 |
| 22 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.04880551 |
| 23 | * ZNF263_19887448_ChIP-Seq_K562_Human | 2.02503414 |
| 24 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.97008142 |
| 25 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.95241241 |
| 26 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.84321256 |
| 27 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.80452298 |
| 28 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.80116674 |
| 29 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.77631950 |
| 30 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.77508864 |
| 31 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.77091438 |
| 32 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.76877867 |
| 33 | TP53_16413492_ChIP-PET_HCT116_Human | 1.74041200 |
| 34 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.73783551 |
| 35 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.73719896 |
| 36 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.71922320 |
| 37 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.71391257 |
| 38 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.70116768 |
| 39 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.66078539 |
| 40 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.65430362 |
| 41 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.65081553 |
| 42 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.64290613 |
| 43 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.63907656 |
| 44 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.59625401 |
| 45 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.59588284 |
| 46 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.59355125 |
| 47 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.59125396 |
| 48 | ATF3_27146783_Chip-Seq_COLON_Human | 1.58227151 |
| 49 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.57540607 |
| 50 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.56277847 |
| 51 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.55303767 |
| 52 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.55277842 |
| 53 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.55277842 |
| 54 | * PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.54994309 |
| 55 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.54711416 |
| 56 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.54695890 |
| 57 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.53356911 |
| 58 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.52482692 |
| 59 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.51930332 |
| 60 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.51930332 |
| 61 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.51789542 |
| 62 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.51351225 |
| 63 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.49039298 |
| 64 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.45520713 |
| 65 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.45317415 |
| 66 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.45147292 |
| 67 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.41510131 |
| 68 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.41010649 |
| 69 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.38859614 |
| 70 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.38848353 |
| 71 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.38666315 |
| 72 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.38143651 |
| 73 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.36256954 |
| 74 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.36117671 |
| 75 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.36084214 |
| 76 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.34587090 |
| 77 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.33774566 |
| 78 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.33518186 |
| 79 | CJUN_26792858_Chip-Seq_BT549_Human | 1.32640753 |
| 80 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.31539332 |
| 81 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.30435355 |
| 82 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.30023604 |
| 83 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.29792207 |
| 84 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.28835134 |
| 85 | * CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.28356343 |
| 86 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.28038504 |
| 87 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.27317503 |
| 88 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.26609377 |
| 89 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.25731509 |
| 90 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.25353978 |
| 91 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.24171603 |
| 92 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.23516324 |
| 93 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.23432223 |
| 94 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.22871721 |
| 95 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.22649605 |
| 96 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.21093019 |
| 97 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.19745447 |
| 98 | RXR_22108803_ChIP-Seq_LS180_Human | 1.19654134 |
| 99 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.19023759 |
| 100 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.18952621 |
| 101 | AR_19668381_ChIP-Seq_PC3_Human | 1.18125729 |
| 102 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.17790763 |
| 103 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.16945037 |
| 104 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.16543117 |
| 105 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.16344901 |
| 106 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.16002021 |
| 107 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.15961869 |
| 108 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.14937615 |
| 109 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.14908432 |
| 110 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.14417756 |
| 111 | GATA1_22025678_ChIP-Seq_K562_Human | 1.14363148 |
| 112 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.13441142 |
| 113 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.11955890 |
| 114 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.11523800 |
| 115 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.11288100 |
| 116 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.10245292 |
| 117 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.10241554 |
| 118 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 1.08458191 |
| 119 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.08458168 |
| 120 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.08402349 |
| 121 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.08253199 |
| 122 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.07986451 |
| 123 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.07964145 |
| 124 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.07447467 |
| 125 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.07283937 |
| 126 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.06937097 |
| 127 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.06054740 |
| 128 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.05953770 |
| 129 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.05463381 |
| 130 | KDM2B_26808549_Chip-Seq_K562_Human | 1.05296115 |
| 131 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.05110138 |
| 132 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.04530451 |
| 133 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.04420269 |
| 134 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.03726827 |
| 135 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.03565350 |
| 136 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.02599962 |
| 137 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.02113909 |
| 138 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.01683711 |
| 139 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.01650442 |
| 140 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.00857429 |
| 141 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.99940020 |
| 142 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.99522526 |
| 143 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.99421247 |
| 144 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.98586269 |
| 145 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.98444476 |
| 146 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.98331640 |
| 147 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.98209249 |
| 148 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.97787632 |
| 149 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.97650262 |
| 150 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.97402570 |
| 151 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.97261033 |
| 152 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.97259160 |
| 153 | * STAT3_23295773_ChIP-Seq_U87_Human | 0.96806583 |
| 154 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.95876747 |
| 155 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.95220378 |
| 156 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.94113105 |
| 157 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.94025937 |
| 158 | * SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.93735772 |
| 159 | * GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.93229248 |
| 160 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.91975250 |
| 161 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.91493822 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 4.53716830 |
| 2 | MP0000751_myopathy | 3.79930673 |
| 3 | MP0008438_abnormal_cutaneous_collagen | 3.71845521 |
| 4 | MP0004084_abnormal_cardiac_muscle | 3.51196859 |
| 5 | MP0003950_abnormal_plasma_membrane | 3.47415425 |
| 6 | MP0004145_abnormal_muscle_electrophysio | 3.10098270 |
| 7 | * MP0004215_abnormal_myocardial_fiber | 3.02237668 |
| 8 | MP0004130_abnormal_muscle_cell | 2.69902275 |
| 9 | MP0004036_abnormal_muscle_relaxation | 2.63965443 |
| 10 | MP0003705_abnormal_hypodermis_morpholog | 2.62512319 |
| 11 | MP0010352_gastrointestinal_tract_polyps | 2.60526363 |
| 12 | MP0000749_muscle_degeneration | 2.52314130 |
| 13 | MP0003646_muscle_fatigue | 2.50454872 |
| 14 | MP0005275_abnormal_skin_tensile | 2.31333368 |
| 15 | MP0004087_abnormal_muscle_fiber | 2.30990309 |
| 16 | MP0005330_cardiomyopathy | 2.18980826 |
| 17 | MP0005503_abnormal_tendon_morphology | 2.13304294 |
| 18 | MP0008775_abnormal_heart_ventricle | 2.06811358 |
| 19 | MP0005620_abnormal_muscle_contractility | 2.03909363 |
| 20 | MP0005023_abnormal_wound_healing | 2.03684047 |
| 21 | * MP0002972_abnormal_cardiac_muscle | 2.03338288 |
| 22 | MP0004859_abnormal_synaptic_plasticity | 1.98264234 |
| 23 | MP0000013_abnormal_adipose_tissue | 1.85935252 |
| 24 | MP0003191_abnormal_cellular_cholesterol | 1.84809647 |
| 25 | MP0000569_abnormal_digit_pigmentation | 1.83705922 |
| 26 | MP0000750_abnormal_muscle_regeneration | 1.83417894 |
| 27 | MP0004233_abnormal_muscle_weight | 1.82645672 |
| 28 | * MP0004484_altered_response_of | 1.80932735 |
| 29 | MP0002060_abnormal_skin_morphology | 1.80369565 |
| 30 | MP0003279_aneurysm | 1.79974411 |
| 31 | MP0004272_abnormal_basement_membrane | 1.79082177 |
| 32 | MP0006054_spinal_hemorrhage | 1.74273106 |
| 33 | MP0009780_abnormal_chondrocyte_physiolo | 1.74172368 |
| 34 | MP0002106_abnormal_muscle_physiology | 1.73705563 |
| 35 | MP0002269_muscular_atrophy | 1.72881047 |
| 36 | MP0010630_abnormal_cardiac_muscle | 1.71989023 |
| 37 | MP0000747_muscle_weakness | 1.71240952 |
| 38 | MP0006138_congestive_heart_failure | 1.66876399 |
| 39 | MP0000759_abnormal_skeletal_muscle | 1.65599682 |
| 40 | MP0002108_abnormal_muscle_morphology | 1.63779352 |
| 41 | MP0005666_abnormal_adipose_tissue | 1.62785145 |
| 42 | MP0005623_abnormal_meninges_morphology | 1.62769690 |
| 43 | MP0005369_muscle_phenotype | 1.61924568 |
| 44 | MP0003828_pulmonary_edema | 1.61750223 |
| 45 | * MP0003137_abnormal_impulse_conducting | 1.60138385 |
| 46 | MP0001544_abnormal_cardiovascular_syste | 1.59813845 |
| 47 | MP0005385_cardiovascular_system_phenoty | 1.59813845 |
| 48 | MP0001299_abnormal_eye_distance/ | 1.54936869 |
| 49 | MP0005670_abnormal_white_adipose | 1.53335412 |
| 50 | MP0003941_abnormal_skin_development | 1.52811322 |
| 51 | MP0009384_cardiac_valve_regurgitation | 1.45969014 |
| 52 | MP0001958_emphysema | 1.42266697 |
| 53 | MP0005164_abnormal_response_to | 1.36646597 |
| 54 | MP0001661_extended_life_span | 1.35862910 |
| 55 | MP0005375_adipose_tissue_phenotype | 1.35182608 |
| 56 | * MP0004085_abnormal_heartbeat | 1.35024853 |
| 57 | MP0003045_fibrosis | 1.33964570 |
| 58 | MP0003868_abnormal_feces_composition | 1.33728983 |
| 59 | MP0009046_muscle_twitch | 1.30934722 |
| 60 | MP0000003_abnormal_adipose_tissue | 1.30814862 |
| 61 | MP0003566_abnormal_cell_adhesion | 1.25486992 |
| 62 | MP0000762_abnormal_tongue_morphology | 1.21939875 |
| 63 | MP0004858_abnormal_nervous_system | 1.21049678 |
| 64 | MP0001542_abnormal_bone_strength | 1.20699552 |
| 65 | MP0004185_abnormal_adipocyte_glucose | 1.19764803 |
| 66 | MP0010368_abnormal_lymphatic_system | 1.18644127 |
| 67 | MP0000733_abnormal_muscle_development | 1.16955068 |
| 68 | MP0004510_myositis | 1.16215367 |
| 69 | MP0009053_abnormal_anal_canal | 1.11910766 |
| 70 | MP0005165_increased_susceptibility_to | 1.10992781 |
| 71 | MP0002909_abnormal_adrenal_gland | 1.09327881 |
| 72 | MP0003453_abnormal_keratinocyte_physiol | 1.07872294 |
| 73 | MP0002896_abnormal_bone_mineralization | 1.07781510 |
| 74 | MP0005197_abnormal_uvea_morphology | 1.07495713 |
| 75 | MP0009840_abnormal_foam_cell | 1.05999578 |
| 76 | MP0003635_abnormal_synaptic_transmissio | 1.01430803 |
| 77 | MP0005187_abnormal_penis_morphology | 1.00861490 |
| 78 | MP0000858_altered_metastatic_potential | 0.99750137 |
| 79 | MP0005409_darkened_coat_color | 0.99502847 |
| 80 | MP0001915_intracranial_hemorrhage | 0.99146460 |
| 81 | MP0002332_abnormal_exercise_endurance | 0.97116454 |
| 82 | MP0001243_abnormal_dermal_layer | 0.96463522 |
| 83 | MP0005257_abnormal_intraocular_pressure | 0.92733340 |
| 84 | MP0005248_abnormal_Harderian_gland | 0.91705453 |
| 85 | MP0010030_abnormal_orbit_morphology | 0.91543250 |
| 86 | MP0004147_increased_porphyrin_level | 0.90176328 |
| 87 | MP0000266_abnormal_heart_morphology | 0.89558825 |
| 88 | MP0003283_abnormal_digestive_organ | 0.88967891 |
| 89 | MP0005058_abnormal_lysosome_morphology | 0.87311412 |
| 90 | MP0010386_abnormal_urinary_bladder | 0.86888276 |
| 91 | MP0001849_ear_inflammation | 0.86720042 |
| 92 | MP0002971_abnormal_brown_adipose | 0.84195820 |
| 93 | MP0008569_lethality_at_weaning | 0.83866500 |
| 94 | MP0002295_abnormal_pulmonary_circulatio | 0.80579993 |
| 95 | MP0002234_abnormal_pharynx_morphology | 0.79401996 |
| 96 | MP0003385_abnormal_body_wall | 0.78531962 |
| 97 | MP0003221_abnormal_cardiomyocyte_apopto | 0.78085069 |
| 98 | MP0003122_maternal_imprinting | 0.77732648 |
| 99 | MP0003091_abnormal_cell_migration | 0.76854372 |
| 100 | MP0000767_abnormal_smooth_muscle | 0.76588831 |
| 101 | MP0002128_abnormal_blood_circulation | 0.75068684 |
| 102 | MP0000627_abnormal_mammary_gland | 0.74912367 |
| 103 | MP0000163_abnormal_cartilage_morphology | 0.74664992 |
| 104 | MP0005193_abnormal_anterior_eye | 0.73373439 |
| 105 | MP0003942_abnormal_urinary_system | 0.71433873 |
| 106 | MP0002970_abnormal_white_adipose | 0.70240248 |
| 107 | MP0001614_abnormal_blood_vessel | 0.69726521 |
| 108 | MP0005508_abnormal_skeleton_morphology | 0.68654943 |
| 109 | MP0002139_abnormal_hepatobiliary_system | 0.68521272 |
| 110 | MP0002090_abnormal_vision | 0.68235322 |
| 111 | MP0010234_abnormal_vibrissa_follicle | 0.67021754 |
| 112 | MP0002168_other_aberrant_phenotype | 0.66567220 |
| 113 | MP0000343_altered_response_to | 0.66543583 |
| 114 | MP0005408_hypopigmentation | 0.66269506 |
| 115 | MP0003329_amyloid_beta_deposits | 0.66160701 |
| 116 | MP0008961_abnormal_basal_metabolism | 0.65869650 |
| 117 | MP0003690_abnormal_glial_cell | 0.65837164 |
| 118 | MP0010678_abnormal_skin_adnexa | 0.65829296 |
| 119 | MP0009697_abnormal_copulation | 0.65457602 |
| 120 | MP0003959_abnormal_lean_body | 0.65393976 |
| 121 | MP0001879_abnormal_lymphatic_vessel | 0.64974300 |
| 122 | MP0003633_abnormal_nervous_system | 0.64125928 |
| 123 | MP0004270_analgesia | 0.63901823 |
| 124 | MP0003567_abnormal_fetal_cardiomyocyte | 0.63586175 |
| 125 | MP0009250_abnormal_appendicular_skeleto | 0.63421596 |
| 126 | MP0005076_abnormal_cell_differentiation | 0.62938843 |
| 127 | MP0005621_abnormal_cell_physiology | 0.62818037 |
| 128 | MP0002127_abnormal_cardiovascular_syste | 0.62189831 |
| 129 | MP0009115_abnormal_fat_cell | 0.61925428 |
| 130 | MP0001348_abnormal_lacrimal_gland | 0.61475700 |
| 131 | MP0000534_abnormal_ureter_morphology | 0.60841722 |
| 132 | MP0004782_abnormal_surfactant_physiolog | 0.60329111 |
| 133 | MP0002063_abnormal_learning/memory/cond | 0.60043891 |
| 134 | MP0003448_altered_tumor_morphology | 0.60031350 |
| 135 | MP0002877_abnormal_melanocyte_morpholog | 0.59320774 |
| 136 | MP0002064_seizures | 0.58912929 |
| 137 | MP0005595_abnormal_vascular_smooth | 0.58808396 |
| 138 | MP0000537_abnormal_urethra_morphology | 0.58401493 |
| 139 | MP0000428_abnormal_craniofacial_morphol | 0.57586359 |
| 140 | MP0002925_abnormal_cardiovascular_devel | 0.56390823 |
| 141 | MP0002067_abnormal_sensory_capabilities | 0.55828953 |
| 142 | MP0005334_abnormal_fat_pad | 0.55635288 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sudden death (HP:0001699) | 4.55231039 |
| 2 | Vertebral compression fractures (HP:0002953) | 4.18064038 |
| 3 | Exercise-induced muscle cramps (HP:0003710) | 4.13456478 |
| 4 | Exercise-induced myalgia (HP:0003738) | 3.87036660 |
| 5 | Calf muscle hypertrophy (HP:0008981) | 3.80239979 |
| 6 | Osteolytic defects of the hand bones (HP:0009699) | 3.68935119 |
| 7 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 3.68935119 |
| 8 | Abnormality of the calf musculature (HP:0001430) | 3.61225932 |
| 9 | Atrial fibrillation (HP:0005110) | 3.60250969 |
| 10 | Increased connective tissue (HP:0009025) | 3.58936629 |
| 11 | Broad metatarsal (HP:0001783) | 3.58667312 |
| 12 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.54583615 |
| 13 | Cerebral aneurysm (HP:0004944) | 3.47294920 |
| 14 | Type 1 muscle fiber predominance (HP:0003803) | 3.46261427 |
| 15 | Wormian bones (HP:0002645) | 3.36659063 |
| 16 | Primary atrial arrhythmia (HP:0001692) | 3.30645311 |
| 17 | Hyporeflexia of lower limbs (HP:0002600) | 3.24282120 |
| 18 | Protrusio acetabuli (HP:0003179) | 3.22564544 |
| 19 | Cervical subluxation (HP:0003308) | 3.20683399 |
| 20 | Shallow orbits (HP:0000586) | 3.19011592 |
| 21 | Right ventricular cardiomyopathy (HP:0011663) | 3.18184164 |
| 22 | Short nail (HP:0001799) | 3.09180042 |
| 23 | Follicular hyperkeratosis (HP:0007502) | 3.08964018 |
| 24 | Ventricular tachycardia (HP:0004756) | 3.08408456 |
| 25 | Supraventricular tachycardia (HP:0004755) | 3.07092244 |
| 26 | Supraventricular arrhythmia (HP:0005115) | 3.06926613 |
| 27 | Syncope (HP:0001279) | 3.04976162 |
| 28 | Muscle fiber splitting (HP:0003555) | 3.00443288 |
| 29 | Myoglobinuria (HP:0002913) | 3.00110229 |
| 30 | Lipoatrophy (HP:0100578) | 2.96504133 |
| 31 | Myotonia (HP:0002486) | 2.90916502 |
| 32 | Bundle branch block (HP:0011710) | 2.90260406 |
| 33 | Asymmetric septal hypertrophy (HP:0001670) | 2.87914742 |
| 34 | Difficulty running (HP:0009046) | 2.87734330 |
| 35 | Cardiovascular calcification (HP:0011915) | 2.86133995 |
| 36 | Premature rupture of membranes (HP:0001788) | 2.85392633 |
| 37 | Prolonged QT interval (HP:0001657) | 2.85131183 |
| 38 | Mitral stenosis (HP:0001718) | 2.84224505 |
| 39 | Aortic aneurysm (HP:0004942) | 2.81744786 |
| 40 | EMG: myopathic abnormalities (HP:0003458) | 2.75342114 |
| 41 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.71144011 |
| 42 | Subaortic stenosis (HP:0001682) | 2.71144011 |
| 43 | Abnormality of dentin (HP:0010299) | 2.69977934 |
| 44 | Spondylolisthesis (HP:0003302) | 2.69935299 |
| 45 | Dysmetric saccades (HP:0000641) | 2.67081108 |
| 46 | Aortic dissection (HP:0002647) | 2.67072167 |
| 47 | Increased variability in muscle fiber diameter (HP:0003557) | 2.66190595 |
| 48 | Ventricular arrhythmia (HP:0004308) | 2.64719302 |
| 49 | Elbow flexion contracture (HP:0002987) | 2.52071814 |
| 50 | Vascular calcification (HP:0004934) | 2.44074641 |
| 51 | Scapular winging (HP:0003691) | 2.42262295 |
| 52 | Action tremor (HP:0002345) | 2.39710295 |
| 53 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.36123417 |
| 54 | Abnormality of the acetabulum (HP:0003170) | 2.35083811 |
| 55 | Arterial tortuosity (HP:0005116) | 2.34553194 |
| 56 | Lymphangioma (HP:0100764) | 2.33590374 |
| 57 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.33482442 |
| 58 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.33289187 |
| 59 | Ankle contracture (HP:0006466) | 2.31604720 |
| 60 | Ventricular fibrillation (HP:0001663) | 2.30762352 |
| 61 | Blue sclerae (HP:0000592) | 2.30333577 |
| 62 | Hypoplastic ischia (HP:0003175) | 2.29382091 |
| 63 | Mitral valve prolapse (HP:0001634) | 2.28355112 |
| 64 | Ulnar bowing (HP:0003031) | 2.26320380 |
| 65 | Aneurysm (HP:0002617) | 2.25094972 |
| 66 | Abnormal delivery (HP:0001787) | 2.22248178 |
| 67 | Mitral regurgitation (HP:0001653) | 2.21877800 |
| 68 | Vascular tortuosity (HP:0004948) | 2.21389404 |
| 69 | Dilated cardiomyopathy (HP:0001644) | 2.18230840 |
| 70 | Spinal rigidity (HP:0003306) | 2.16531902 |
| 71 | Glucose intolerance (HP:0000833) | 2.16492089 |
| 72 | Difficulty climbing stairs (HP:0003551) | 2.13303617 |
| 73 | Abnormality of the ischium (HP:0003174) | 2.11529206 |
| 74 | Abnormality of carpal bone ossification (HP:0006257) | 2.10564704 |
| 75 | Abnormal EKG (HP:0003115) | 2.08918515 |
| 76 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.08811013 |
| 77 | Upper limb amyotrophy (HP:0009129) | 2.06662901 |
| 78 | Distal upper limb amyotrophy (HP:0007149) | 2.06662901 |
| 79 | Dilatation of the ascending aorta (HP:0005111) | 2.05982391 |
| 80 | Coxa vara (HP:0002812) | 2.05634978 |
| 81 | Skin nodule (HP:0200036) | 2.03884828 |
| 82 | Striae distensae (HP:0001065) | 2.03432598 |
| 83 | Nuclear cataract (HP:0100018) | 2.03246646 |
| 84 | Tetraparesis (HP:0002273) | 2.02433615 |
| 85 | Myocardial infarction (HP:0001658) | 2.02248893 |
| 86 | Natal tooth (HP:0000695) | 2.00998940 |
| 87 | Biconcave vertebral bodies (HP:0004586) | 1.99971491 |
| 88 | Palpitations (HP:0001962) | 1.99134652 |
| 89 | Ketoacidosis (HP:0001993) | 1.96600310 |
| 90 | Aortic regurgitation (HP:0001659) | 1.96578516 |
| 91 | Neonatal short-limb short stature (HP:0008921) | 1.96467001 |
| 92 | Slender build (HP:0001533) | 1.94503093 |
| 93 | Hyperextensible skin (HP:0000974) | 1.94127511 |
| 94 | Enlarged penis (HP:0000040) | 1.93966800 |
| 95 | Abnormal atrioventricular conduction (HP:0005150) | 1.93458975 |
| 96 | Heart block (HP:0012722) | 1.92012385 |
| 97 | Back pain (HP:0003418) | 1.91466541 |
| 98 | Neurofibrillary tangles (HP:0002185) | 1.91458250 |
| 99 | Coronal craniosynostosis (HP:0004440) | 1.89991055 |
| 100 | Atrophic scars (HP:0001075) | 1.89788600 |
| 101 | Abnormality of the intrinsic pathway (HP:0010989) | 1.89033260 |
| 102 | Conjugated hyperbilirubinemia (HP:0002908) | 1.88892012 |
| 103 | Generalized amyotrophy (HP:0003700) | 1.87087707 |
| 104 | Joint laxity (HP:0001388) | 1.86738332 |
| 105 | Acanthosis nigricans (HP:0000956) | 1.86377269 |
| 106 | Round ear (HP:0100830) | 1.85855922 |
| 107 | Muscle fiber inclusion bodies (HP:0100299) | 1.85844264 |
| 108 | Broad face (HP:0000283) | 1.85106282 |
| 109 | Hydroxyprolinuria (HP:0003080) | 1.83726719 |
| 110 | Abnormality of proline metabolism (HP:0010907) | 1.83726719 |
| 111 | Achilles tendon contracture (HP:0001771) | 1.83189821 |
| 112 | Abnormal ossification of hand bones (HP:0005921) | 1.83098041 |
| 113 | Knee flexion contracture (HP:0006380) | 1.82592469 |
| 114 | Proximal amyotrophy (HP:0007126) | 1.82373275 |
| 115 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.82047770 |
| 116 | Lower limb amyotrophy (HP:0007210) | 1.81929747 |
| 117 | Cerebral inclusion bodies (HP:0100314) | 1.80937643 |
| 118 | Hypoalphalipoproteinemia (HP:0003233) | 1.80483745 |
| 119 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.80396522 |
| 120 | Soft skin (HP:0000977) | 1.79403943 |
| 121 | Distal lower limb amyotrophy (HP:0008944) | 1.78138655 |
| 122 | Fragile skin (HP:0001030) | 1.77544815 |
| 123 | Bladder diverticulum (HP:0000015) | 1.77383199 |
| 124 | Abnormality of the common coagulation pathway (HP:0010990) | 1.76578058 |
| 125 | Deep venous thrombosis (HP:0002625) | 1.76269291 |
| 126 | Ankyloglossia (HP:0010296) | 1.75748970 |
| 127 | Syringomyelia (HP:0003396) | 1.74864824 |
| 128 | Spinal cord lesions (HP:0100561) | 1.74864824 |
| 129 | Distal lower limb muscle weakness (HP:0009053) | 1.74201563 |
| 130 | Hyperacusis (HP:0010780) | 1.73535992 |
| 131 | Focal segmental glomerulosclerosis (HP:0000097) | 1.73200836 |
| 132 | Spinal cord compression (HP:0002176) | 1.72806147 |
| 133 | Termporal pattern (HP:0011008) | 1.72488384 |
| 134 | Insidious onset (HP:0003587) | 1.72488384 |
| 135 | Muscle stiffness (HP:0003552) | 1.72468906 |
| 136 | Turricephaly (HP:0000262) | 1.70029613 |
| 137 | Overgrowth (HP:0001548) | 1.69885387 |
| 138 | Rhabdomyolysis (HP:0003201) | 1.69775068 |
| 139 | Abnormality of oral frenula (HP:0000190) | 1.69434433 |
| 140 | Abnormality of the 4th metacarpal (HP:0010012) | 1.67677276 |
| 141 | Protruding ear (HP:0000411) | 1.67008223 |
| 142 | Limb-girdle muscle atrophy (HP:0003797) | 1.66858904 |
| 143 | Focal seizures (HP:0007359) | 1.66552021 |
| 144 | Muscular dystrophy (HP:0003560) | 1.66126229 |
| 145 | Pterygium (HP:0001059) | 1.65868582 |
| 146 | Advanced eruption of teeth (HP:0006288) | 1.65799807 |
| 147 | Delayed cranial suture closure (HP:0000270) | 1.65617258 |
| 148 | Visual hallucinations (HP:0002367) | 1.65098297 |
| 149 | Narrow palate (HP:0000189) | 1.65040429 |
| 150 | Genu recurvatum (HP:0002816) | 1.64767631 |
| 151 | Insulin resistance (HP:0000855) | 1.64266613 |
| 152 | Buphthalmos (HP:0000557) | 1.63664720 |
| 153 | Exostoses (HP:0100777) | 1.63416888 |
| 154 | Absent frontal sinuses (HP:0002688) | 1.63335529 |
| 155 | Focal motor seizures (HP:0011153) | 1.63294329 |
| 156 | Abnormality of the Achilles tendon (HP:0005109) | 1.62817360 |
| 157 | Atrioventricular block (HP:0001678) | 1.61294552 |
| 158 | Bell-shaped thorax (HP:0001591) | 1.60671473 |
| 159 | Long toe (HP:0010511) | 1.60615145 |
| 160 | Hamartoma of the eye (HP:0010568) | 1.59816505 |
| 161 | Distal arthrogryposis (HP:0005684) | 1.59653302 |
| 162 | Subacute progressive viral hepatitis (HP:0006572) | 1.58338300 |
| 163 | Macroorchidism (HP:0000053) | 1.58263165 |
| 164 | Short 4th metacarpal (HP:0010044) | 1.56459544 |
| 165 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 1.56459544 |
| 166 | Genetic anticipation (HP:0003743) | 1.55424123 |
| 167 | Frequent falls (HP:0002359) | 1.55364244 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MST1R | 6.27345869 |
| 2 | TTN | 4.09590961 |
| 3 | MET | 4.07693022 |
| 4 | EPHA2 | 3.32593090 |
| 5 | ERBB4 | 2.84013954 |
| 6 | LMTK2 | 2.83678702 |
| 7 | RIPK1 | 2.81655148 |
| 8 | PHKG2 | 2.69472611 |
| 9 | PHKG1 | 2.69472611 |
| 10 | PKN2 | 2.63103065 |
| 11 | TRIB3 | 2.58109326 |
| 12 | OBSCN | 2.48769045 |
| 13 | CAMK1D | 2.31125764 |
| 14 | DMPK | 2.24421709 |
| 15 | CAMK1G | 2.11661841 |
| 16 | SIK1 | 2.01046227 |
| 17 | LIMK1 | 2.00852308 |
| 18 | TESK1 | 2.00703545 |
| 19 | PDGFRA | 2.00141690 |
| 20 | TGFBR2 | 1.97651906 |
| 21 | PAK4 | 1.97132622 |
| 22 | IRAK3 | 1.96496295 |
| 23 | CAMKK2 | 1.94969071 |
| 24 | DDR2 | 1.84333811 |
| 25 | PIK3CA | 1.74859050 |
| 26 | LATS1 | 1.73164603 |
| 27 | FRK | 1.66563863 |
| 28 | PDK3 | 1.59582713 |
| 29 | PDK4 | 1.59582713 |
| 30 | NEK1 | 1.56109601 |
| 31 | ICK | 1.52532286 |
| 32 | AKT3 | 1.40804584 |
| 33 | ERN1 | 1.40799798 |
| 34 | NTRK3 | 1.35784696 |
| 35 | MOS | 1.32178996 |
| 36 | CAMKK1 | 1.30509898 |
| 37 | FER | 1.28686781 |
| 38 | PDK2 | 1.27526781 |
| 39 | MAP3K4 | 1.27521694 |
| 40 | LATS2 | 1.24230309 |
| 41 | MYLK | 1.19895845 |
| 42 | EPHB1 | 1.18815468 |
| 43 | MAP2K4 | 1.17371440 |
| 44 | WNK1 | 1.17107664 |
| 45 | MAP3K9 | 1.15471774 |
| 46 | STK38 | 1.15426848 |
| 47 | CDK8 | 1.13528106 |
| 48 | PTK6 | 1.09693560 |
| 49 | SCYL2 | 1.09525116 |
| 50 | FGFR2 | 1.09458845 |
| 51 | STK38L | 1.07884085 |
| 52 | EEF2K | 1.07330580 |
| 53 | MAP3K12 | 1.03546502 |
| 54 | PAK3 | 1.03083228 |
| 55 | PBK | 1.02635960 |
| 56 | INSRR | 1.02030471 |
| 57 | EIF2AK1 | 1.01789102 |
| 58 | RET | 1.01704002 |
| 59 | PAK6 | 1.00561287 |
| 60 | BMX | 0.96575157 |
| 61 | CAMK4 | 0.95431673 |
| 62 | BRSK2 | 0.94819036 |
| 63 | MINK1 | 0.94344060 |
| 64 | PLK2 | 0.93261896 |
| 65 | ARAF | 0.91497389 |
| 66 | GRK7 | 0.89721514 |
| 67 | KSR2 | 0.89578641 |
| 68 | NEK9 | 0.89405737 |
| 69 | ABL2 | 0.88566336 |
| 70 | PINK1 | 0.87227763 |
| 71 | DAPK2 | 0.86153613 |
| 72 | KSR1 | 0.85025595 |
| 73 | SGK3 | 0.84077358 |
| 74 | MAP3K7 | 0.83990121 |
| 75 | MAPK12 | 0.83735612 |
| 76 | PRKAA2 | 0.81898498 |
| 77 | FGFR1 | 0.81098343 |
| 78 | NME2 | 0.78824835 |
| 79 | PRKAA1 | 0.77763747 |
| 80 | EPHB2 | 0.76439725 |
| 81 | ROCK1 | 0.74789305 |
| 82 | PRKD1 | 0.74141949 |
| 83 | CAMK1 | 0.73704529 |
| 84 | ERBB3 | 0.73139239 |
| 85 | MELK | 0.71782210 |
| 86 | TRPM7 | 0.71777296 |
| 87 | STK39 | 0.70801711 |
| 88 | PTK2 | 0.70081989 |
| 89 | SGK2 | 0.68852263 |
| 90 | MST4 | 0.68798625 |
| 91 | CDC42BPA | 0.68526189 |
| 92 | JAK1 | 0.67776223 |
| 93 | FGFR3 | 0.66034550 |
| 94 | NTRK1 | 0.65986978 |
| 95 | PDGFRB | 0.65986418 |
| 96 | PTK2B | 0.65245394 |
| 97 | PRKD3 | 0.64567254 |
| 98 | BRSK1 | 0.63462995 |
| 99 | PRKCH | 0.62630595 |
| 100 | MAPKAPK3 | 0.61848017 |
| 101 | MAP3K2 | 0.61601721 |
| 102 | CAMK2D | 0.60762468 |
| 103 | STK24 | 0.59116278 |
| 104 | EIF2AK3 | 0.58940486 |
| 105 | SGK1 | 0.56662346 |
| 106 | MAP2K1 | 0.56079110 |
| 107 | BCKDK | 0.55283663 |
| 108 | CDK12 | 0.51100633 |
| 109 | GSK3A | 0.51064889 |
| 110 | MTOR | 0.50080421 |
| 111 | PAK2 | 0.49629283 |
| 112 | PRKCE | 0.49504217 |
| 113 | CAMK2A | 0.48880200 |
| 114 | PRKG2 | 0.48792002 |
| 115 | PDPK1 | 0.47989230 |
| 116 | CAMK2G | 0.47582524 |
| 117 | STK10 | 0.46490980 |
| 118 | STK3 | 0.45089999 |
| 119 | SIK2 | 0.43918798 |
| 120 | PDK1 | 0.43008988 |
| 121 | CDK5 | 0.42606947 |
| 122 | AKT2 | 0.42443535 |
| 123 | CDK6 | 0.40792307 |
| 124 | FLT3 | 0.40645301 |
| 125 | MAP3K3 | 0.40339527 |
| 126 | RPS6KA3 | 0.40315991 |
| 127 | WNK4 | 0.38886853 |
| 128 | PIK3CG | 0.38686473 |
| 129 | PRKACB | 0.38662443 |
| 130 | ROCK2 | 0.38597557 |
| 131 | ERBB2 | 0.38455661 |
| 132 | MAP3K6 | 0.38161199 |
| 133 | ILK | 0.38126113 |
| 134 | JAK2 | 0.37903100 |
| 135 | SGK494 | 0.37633700 |
| 136 | SGK223 | 0.37633700 |
| 137 | EPHA3 | 0.37039077 |
| 138 | SRC | 0.35406741 |
| 139 | PRKD2 | 0.35153514 |
| 140 | GRK5 | 0.35042831 |
| 141 | FGFR4 | 0.32913620 |
| 142 | CDK9 | 0.31455826 |
| 143 | MAP3K13 | 0.31408141 |
| 144 | NEK2 | 0.30310838 |
| 145 | MAP3K8 | 0.30014992 |
| 146 | CAMK2B | 0.29152063 |
| 147 | PIM2 | 0.27258331 |
| 148 | MAPK11 | 0.27099684 |
| 149 | ADRBK1 | 0.25468321 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.73582155 |
| 2 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.54648663 |
| 3 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.32627518 |
| 4 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.04255843 |
| 5 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.92892171 |
| 6 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.88968065 |
| 7 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.84819460 |
| 8 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.77972446 |
| 9 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.72003809 |
| 10 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.66333613 |
| 11 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.57913874 |
| 12 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.54557610 |
| 13 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.48542843 |
| 14 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.47714453 |
| 15 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.47287367 |
| 16 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.47193170 |
| 17 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.45982820 |
| 18 | Renin secretion_Homo sapiens_hsa04924 | 1.45454605 |
| 19 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.44300155 |
| 20 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.43626994 |
| 21 | Galactose metabolism_Homo sapiens_hsa00052 | 1.42526247 |
| 22 | Long-term potentiation_Homo sapiens_hsa04720 | 1.42035401 |
| 23 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.41222508 |
| 24 | Circadian entrainment_Homo sapiens_hsa04713 | 1.39332318 |
| 25 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.38223340 |
| 26 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.37173631 |
| 27 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.37116515 |
| 28 | Nicotine addiction_Homo sapiens_hsa05033 | 1.36932280 |
| 29 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.35816430 |
| 30 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.34704426 |
| 31 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.34532442 |
| 32 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.30078644 |
| 33 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.30028387 |
| 34 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.29170417 |
| 35 | Salivary secretion_Homo sapiens_hsa04970 | 1.28515986 |
| 36 | Focal adhesion_Homo sapiens_hsa04510 | 1.28503330 |
| 37 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.26165349 |
| 38 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.25048744 |
| 39 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.24365022 |
| 40 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.24090862 |
| 41 | Other glycan degradation_Homo sapiens_hsa00511 | 1.24088028 |
| 42 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.23366327 |
| 43 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.23085866 |
| 44 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.18078582 |
| 45 | Insulin secretion_Homo sapiens_hsa04911 | 1.16017646 |
| 46 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.15511018 |
| 47 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.13407179 |
| 48 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.12297667 |
| 49 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.12135425 |
| 50 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.10772628 |
| 51 | GABAergic synapse_Homo sapiens_hsa04727 | 1.09386500 |
| 52 | Insulin resistance_Homo sapiens_hsa04931 | 1.08712026 |
| 53 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.08369934 |
| 54 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.07182285 |
| 55 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.07104234 |
| 56 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.03813111 |
| 57 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.00806610 |
| 58 | Long-term depression_Homo sapiens_hsa04730 | 1.00560065 |
| 59 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.99939864 |
| 60 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.99920231 |
| 61 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.99658835 |
| 62 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.98951252 |
| 63 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.98935967 |
| 64 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.98145206 |
| 65 | Bladder cancer_Homo sapiens_hsa05219 | 0.97849300 |
| 66 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.96095844 |
| 67 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.94645220 |
| 68 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.94612160 |
| 69 | Adherens junction_Homo sapiens_hsa04520 | 0.94567917 |
| 70 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.94493935 |
| 71 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.93957051 |
| 72 | Morphine addiction_Homo sapiens_hsa05032 | 0.93497418 |
| 73 | Amoebiasis_Homo sapiens_hsa05146 | 0.92921285 |
| 74 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.92506926 |
| 75 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.92078719 |
| 76 | Gap junction_Homo sapiens_hsa04540 | 0.91825897 |
| 77 | Glioma_Homo sapiens_hsa05214 | 0.89969058 |
| 78 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.89343844 |
| 79 | Thyroid cancer_Homo sapiens_hsa05216 | 0.89336132 |
| 80 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.87851440 |
| 81 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.86428534 |
| 82 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.86311843 |
| 83 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.85964258 |
| 84 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.84847892 |
| 85 | Taste transduction_Homo sapiens_hsa04742 | 0.84625356 |
| 86 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.83977690 |
| 87 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.83493368 |
| 88 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.82754694 |
| 89 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.82658979 |
| 90 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.82061413 |
| 91 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.81966019 |
| 92 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.81091400 |
| 93 | Olfactory transduction_Homo sapiens_hsa04740 | 0.79643163 |
| 94 | Carbon metabolism_Homo sapiens_hsa01200 | 0.79225193 |
| 95 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.79019269 |
| 96 | Prion diseases_Homo sapiens_hsa05020 | 0.78717481 |
| 97 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.77582198 |
| 98 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.75504193 |
| 99 | Histidine metabolism_Homo sapiens_hsa00340 | 0.74954292 |
| 100 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.73738865 |
| 101 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.73614444 |
| 102 | Melanogenesis_Homo sapiens_hsa04916 | 0.73016794 |
| 103 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.71918759 |
| 104 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.71131664 |
| 105 | Bile secretion_Homo sapiens_hsa04976 | 0.70788970 |
| 106 | Viral myocarditis_Homo sapiens_hsa05416 | 0.70580645 |
| 107 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.68508932 |
| 108 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.66551129 |
| 109 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.64891700 |
| 110 | Platelet activation_Homo sapiens_hsa04611 | 0.64463376 |
| 111 | Circadian rhythm_Homo sapiens_hsa04710 | 0.64237996 |
| 112 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.64108239 |
| 113 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.63885331 |
| 114 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.63591565 |
| 115 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.63307534 |
| 116 | Lysosome_Homo sapiens_hsa04142 | 0.63006675 |
| 117 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.62996672 |
| 118 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.62808734 |
| 119 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.61959115 |
| 120 | Pathways in cancer_Homo sapiens_hsa05200 | 0.61740934 |
| 121 | Lysine degradation_Homo sapiens_hsa00310 | 0.61571684 |
| 122 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.61425765 |
| 123 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.59563803 |
| 124 | Melanoma_Homo sapiens_hsa05218 | 0.59102374 |
| 125 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.57581174 |
| 126 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.57312176 |
| 127 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.57158382 |
| 128 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.56845889 |
| 129 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.53463331 |
| 130 | Axon guidance_Homo sapiens_hsa04360 | 0.53342307 |
| 131 | Endometrial cancer_Homo sapiens_hsa05213 | 0.53188440 |
| 132 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.53176099 |
| 133 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.52484452 |
| 134 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.52358180 |
| 135 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.51098951 |
| 136 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.50388007 |
| 137 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.50323418 |
| 138 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.49967322 |
| 139 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.48181225 |
| 140 | Tight junction_Homo sapiens_hsa04530 | 0.46875538 |
| 141 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.46772566 |
| 142 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.46280633 |
| 143 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.46184811 |
| 144 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.45780196 |
| 145 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.45521344 |
| 146 | Shigellosis_Homo sapiens_hsa05131 | 0.44809608 |
| 147 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.43756221 |
| 148 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.43588081 |
| 149 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.43359599 |
| 150 | Endocytosis_Homo sapiens_hsa04144 | 0.42807853 |

